VDRM — Viaderma Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.37m
- $5.10m
- $0.45m
Annual cashflow statement for Viaderma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2009 December 31st | 2010 December 31st | 2011 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 4.09 | 4.51 | 2.67 | 0.004 | -3.87 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1.26 | 0.862 | 0.002 | 0.343 | 2.91 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.7 | 0.848 | 0.572 | -0.347 | -1.68 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | 3.31 | 7.78 | 6.05 | 0 | -2.63 |
| Capital Expenditures | -5.52 | -7.13 | -9.43 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.005 | 0.002 | 0.004 | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -5.52 | -7.12 | -9.43 | — | — |
| Financing Cash Flow Items | 1.39 | -0.937 | 0.252 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.72 | -0.446 | 2.95 | 0 | 2.63 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.509 | 0.196 | -0.394 | 0 | 0.002 |